Torley Helen

Torley Helen serves as the President and CEO of Halozyme Therapeutics, Inc., a company focused on advancing innovative therapies for patients with unmet medical needs. Under her leadership, Halozyme has made significant strides in the healthcare sector, particularly in developing drug delivery technologies. Between May 13, 2026, and July 9, 2026, she reported 20 disclosures, all related to sale activity, with amounts ranging from $83.0K to $23.2K. The most notable transaction occurred on June 3, 2026, when she sold shares valued at approximately $1.1 million.